What is the name of the target company in which the capital increase will occur?

The target company for the capital increase is ACT TW, also known as ACT Genomics Co., Ltd.

When did the Board of Directors approve this capital increase transaction?

The Board of Directors approved this transaction on January 30, 2026.

What is the total transaction amount planned for this capital increase?

The total transaction amount is approximately NT$1.25 billion.

What is the relationship between the counterparty, ACT KY, and ACT TW?

ACT KY is planning to increase capital for its 100% subsidiary, ACT TW.

How many shares are expected to be transacted in this capital increase?

The expected transaction unit quantity is approximately 125 million shares.

AI News NQ Analysis

Delta Electronics (Supplementary Announcement): Subsidiary ACT Genomics Holdings Company Limited Announces Board Resolution to Increase Capital for ACT TW

NQ Score 73/100

AI Summary (NQ-processed)

Delta Electronics' subsidiary, ACT Genomics Holdings Company Limited (ACT KY), announced a board resolution to increase the capital of its wholly-owned subsidiary, ACT TW. The capital increase involves approximately 125 million shares at NT$10 per share, totaling about NT$1.25 billion. This move aims to meet the funding needs of the subsidiary, bringing ACT KY's cumulative holding in ACT TW to 100% with a total investment of approximately NT$1.499 billion.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the name of the target company in which the capital increase will occur?: A: The target company for the capital increase is ACT TW, also known as ACT Genomics Co., Ltd.
Q: When did the Board of Directors approve this capital increase transaction?: A: The Board of Directors approved this transaction on January 30, 2026.
Q: What is the total transaction amount planned for this capital increase?: A: The total transaction amount is approximately NT$1.25 billion.
Q: What is the relationship between the counterparty, ACT KY, and ACT TW?: A: ACT KY is planning to increase capital for its 100% subsidiary, ACT TW.
Q: How many shares are expected to be transacted in this capital increase?: A: The expected transaction unit quantity is approximately 125 million shares.